{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T01:11:30Z","timestamp":1778721090354,"version":"3.51.4"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001824","name":"Grantov\u00e1 Agentura \u010cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["23-05857"],"award-info":[{"award-number":["23-05857"]}],"id":[{"id":"10.13039\/501100001824","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001824","name":"Grantov\u00e1 Agentura \u010cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["2200\/04\/2024-2026"],"award-info":[{"award-number":["2200\/04\/2024-2026"]}],"id":[{"id":"10.13039\/501100001824","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001824","name":"Grantov\u00e1 Agentura \u010cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["P\\u0159F UHK 2207\/2025-2026"],"award-info":[{"award-number":["P\\u0159F UHK 2207\/2025-2026"]}],"id":[{"id":"10.13039\/501100001824","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001823","name":"Ministry of Education Youth and Sports of the Czech Republic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001823","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019563","name":"Mikrobiologick\u00fd \u00dastav, Akademie V\u011bd \u010cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["LM2023052"],"award-info":[{"award-number":["LM2023052"]}],"id":[{"id":"10.13039\/501100019563","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018512","name":"Univerzita Hradec Kr\u00e1lov\u00e9","doi-asserted-by":"publisher","award":["RVO 68378050"],"award-info":[{"award-number":["RVO 68378050"]}],"id":[{"id":"10.13039\/100018512","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.bioorg.2026.109868","type":"journal-article","created":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T17:33:00Z","timestamp":1776015180000},"page":"109868","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The structure-activity relationship study of torkinib derivatives as mTOR inhibitors with senolytic and STAT3 inhibitory activities"],"prefix":"10.1016","volume":"176","author":[{"given":"Patrik","family":"Oleksak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Rysanek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marketa","family":"Vancurova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josef","family":"Novak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominika","family":"Maurencova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erika","family":"Rousarova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Capek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomas","family":"Rousar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karel","family":"Vales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vojtech","family":"Skopek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martyna Julia","family":"Maslowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kotryna","family":"Gumauskaite","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabrielius","family":"Stankus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamil","family":"Kuca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rudolf","family":"Andrys","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Skarka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miroslav","family":"Lisa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lukas","family":"Fresser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabina","family":"Surovcova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zofia","family":"Chrienova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Popr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugenie","family":"Nepovimova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zdenek","family":"Hodny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2026.109868_bb0005","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nature12122","article-title":"MTOR kinase structure, mechanism and regulation by the rapamycin-binding domain","volume":"497","author":"Yang","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2026.109868_bb0010","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/s41392-023-01608-z","article-title":"Multifaceted role of mTOR (mammalian target of rapamycin) signaling pathway in human health and disease","volume":"8","author":"Panwar","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bioorg.2026.109868_bb0015","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jbior.2019.03.003","article-title":"Diverse signaling mechanisms of mTOR complexes: MTORC1 and mTORC2 in forming a formidable relationship","volume":"72","author":"Jhanwar-Uniyal","year":"2019","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.bioorg.2026.109868_bb0020","first-page":"878","article-title":"4.4 \u00e5 resolution Cryo-EM structure of human mTOR complex 1, protein","volume":"7","author":"Yang","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.bioorg.2026.109868_bb0025","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12943-023-01827-6","article-title":"PI3K\/AKT\/mTOR signaling transduction pathway and targeted therapies in cancer","volume":"22","author":"Glaviano","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bioorg.2026.109868_bb0030","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.cell.2017.02.004","article-title":"MTOR signaling in growth, metabolism, and disease","volume":"168","author":"Saxton","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.bioorg.2026.109868_bb0035","article-title":"Genomic and transcriptome analysis to identify the role of the mTOR pathway in kidney renal clear cell carcinoma and its potential therapeutic significance","volume":"2021","author":"Che","year":"2021","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.bioorg.2026.109868_bb0040","doi-asserted-by":"crossref","DOI":"10.1111\/cns.14463","article-title":"mTOR signaling and alzheimers disease: what we know and where we are?","volume":"30","author":"Davoody","year":"2024","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.bioorg.2026.109868_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.107812","article-title":"Brain-penetrant PQR620 mTOR and PQR530 PI3K\/mTOR inhibitor reduce huntingtin levels in cell models of HD","volume":"162","author":"Singer","year":"2020","journal-title":"Neuropharmacol"},{"key":"10.1016\/j.bioorg.2026.109868_bb0050","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1007\/s00125-016-4188-9","article-title":"Reciprocal regulation of mTOR complexes in pancreatic islets from humans with type 2 diabetes","volume":"60","author":"Yuan","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.bioorg.2026.109868_bb0055","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.tips.2015.11.011","article-title":"Recent advances in adipose mTOR signaling and function: therapeutic prospects","volume":"37","author":"Cai","year":"2016","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bioorg.2026.109868_bb0060","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1126\/science.1115535","article-title":"Regulation of yeast replicative life span by TOR and sch9 in response to nutrients","volume":"310","author":"Kaeberlein","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.bioorg.2026.109868_bb0065","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.cub.2004.03.059","article-title":"Regulation of lifespan in drosophila by modulation of genes in the TOR signaling pathway","volume":"14","author":"Kapahi","year":"2004","journal-title":"Curr. Biol."},{"key":"10.1016\/j.bioorg.2026.109868_bb0070","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1111\/acel.12380","article-title":"Chronic mTOR inhibition in mice with rapamycin alters t, b, myeloid, and innate lymphoid cells and gut flora and prolongs life of immune-deficient mice","volume":"14","author":"Hurez","year":"2015","journal-title":"Aging Cell"},{"key":"10.1016\/j.bioorg.2026.109868_bb0075","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1159\/000484629","article-title":"MTOR as regulator of lifespan, aging, and cellular senescence: a Mini-review","volume":"64","author":"Weichhart","year":"2017","journal-title":"Gerontology"},{"key":"10.1016\/j.bioorg.2026.109868_bb0080","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.cell.2022.11.001","article-title":"Hallmarks of aging: an expanding universe","volume":"186","author":"L\u00f3pez-Ot\u00edn","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.bioorg.2026.109868_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114498","article-title":"Contemporary mTOR inhibitor scaffolds to diseases breakdown: a patent review (2015-2021)","volume":"238","author":"Oleksak","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109868_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112820","article-title":"Research progress of mTOR inhibitors","volume":"208","author":"Chen","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109868_bb0095","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.70152","article-title":"STAT3 signaling pathway in health and disease","volume":"6","author":"Samad","year":"2025","journal-title":"MedComm"},{"key":"10.1016\/j.bioorg.2026.109868_bb0100","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1021\/acsptsci.4c00190","article-title":"Discovery of a 6-Aminobenzo[b]thiophene 1,1-dioxide derivative (k2071) with a signal transducer and activator of transcription 3 inhibitory, antimitotic, and senotherapeutic activities","volume":"7","author":"Oleksak","year":"2024","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.bioorg.2026.109868_bb0105","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17050755","article-title":"Targeting STAT3 for cancer therapy: focusing on y705, s727, or dual inhibition?","volume":"17","author":"Berkley","year":"2025","journal-title":"Cancers"},{"key":"10.1016\/j.bioorg.2026.109868_bb0110","doi-asserted-by":"crossref","first-page":"584","DOI":"10.4049\/jimmunol.1401024","article-title":"Adenosine 5\u2032-monophosphate-activated protein kinase regulates IL-10-mediated anti-inflammatory signaling pathways in macrophages","volume":"194","author":"Zhu","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.bioorg.2026.109868_bb0115","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/s41392-025-02493-4","article-title":"MTOR signaling networks: mechanistic insights and translational frontiers in disease therapeutics","volume":"10","author":"Zhang","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bioorg.2026.109868_bb0120","doi-asserted-by":"crossref","first-page":"83","DOI":"10.21873\/cgp.20021","article-title":"Combination of a STAT3 inhibitor and an mTOR inhibitor against a temozolomide-resistant glioblastoma cell line","volume":"14","author":"Miyata","year":"2017","journal-title":"Cancer Genomics Proteomics"},{"key":"10.1016\/j.bioorg.2026.109868_bb0125","article-title":"Viral manipulation of STAT3: evade, exploit, and injure","volume":"14","author":"Suarez","year":"2018","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.bioorg.2026.109868_bb0130","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.bbcan.2013.12.005","article-title":"Targeting the STAT3 signaling pathway in cancer: role of synthetic and natural inhibitors","volume":"1845","author":"Siveen","year":"2014","journal-title":"Biochim. Biophys. Acta (BBA) - Rev. Cancer"},{"key":"10.1016\/j.bioorg.2026.109868_bb0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1000038","article-title":"Active-site inhibitors of mTOR target rapamycin-resistant outputs of mTORC1 and mTORC2","volume":"7","author":"Feldman","year":"2009","journal-title":"PLoS Biol."},{"key":"10.1016\/j.bioorg.2026.109868_bb0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2013.06.017","article-title":"MTOR kinase inhibitors as potential cancer therapeutic drugs","volume":"340","author":"Sun","year":"2013","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bioorg.2026.109868_bb0145","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nm.2091","article-title":"Effective and selective targeting of leukemia cells using a TORC1\/2 kinase inhibitor","volume":"16","author":"Janes","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.bioorg.2026.109868_bb0150","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1080\/15548627.2019.1659614","article-title":"ZNNT1 long noncoding RNA induces autophagy to inhibit tumorigenesis of uveal melanoma by regulating key autophagy gene expression","volume":"16","author":"Li","year":"2020","journal-title":"Autophagy"},{"key":"10.1016\/j.bioorg.2026.109868_bb0155","series-title":"Kinase Inhibitors and Methods of Use, Intellikine Inc., WO2010006086A2","author":"Ren","year":"2010"},{"key":"10.1016\/j.bioorg.2026.109868_bb0160","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1016\/S0040-4039(01)95429-2","article-title":"A new stereospecific cross-coupling by the palladium-catalyzed reaction of 1-alkenylboranes with 1-alkenyl or 1-alkynyl halides","volume":"20","author":"Miyaura","year":"1979","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.bioorg.2026.109868_bb0165","doi-asserted-by":"crossref","first-page":"44905","DOI":"10.18632\/oncotarget.6457","article-title":"MTOR kinase inhibitor pp242 causes mitophagy terminated by apoptotic cell death in E1A-Ras transformed cells","volume":"6","author":"Gordeev","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.bioorg.2026.109868_bb0170","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.1048260","article-title":"Discovery of small molecule mechanistic target of rapamycin inhibitors as anti-aging and anti-cancer therapeutics","volume":"14","author":"Chrienova","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.bioorg.2026.109868_bb0175","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/nchembio.117","article-title":"Targeted polypharmacology: discovery of dual inhibitors of tyrosine and phosphoinositide kinases","volume":"4","author":"Apsel","year":"2008","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.bioorg.2026.109868_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.tet.2020.131111","article-title":"A stereoselective approach in preparation of gamma-lactam precursors for oxazolomycin\u2019s synthesis","volume":"76","author":"Oleksak","year":"2020","journal-title":"Tetrahedron"},{"key":"10.1016\/j.bioorg.2026.109868_bb0185","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jchromb.2004.10.045","article-title":"Development of a headspace gas chromatographic test for the quantification of 1- and 2-bromopropane in human urine","volume":"814","author":"B\u2019Hymer","year":"2005","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.bioorg.2026.109868_bb0190","doi-asserted-by":"crossref","first-page":"5130","DOI":"10.1016\/j.bmcl.2008.07.090","article-title":"7-[1H-Indol-2-yl]-2,3-dihydro-isoindol-1-ones as dual Aurora-A\/VEGF-R2 kinase inhibitors: design, synthesis, and biological activity","volume":"18","author":"Hughes","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2026.109868_bb0195","doi-asserted-by":"crossref","first-page":"4096","DOI":"10.1039\/C7OB00526A","article-title":"A threonine turnstile defines a dynamic amphiphilic binding motif in the AAA ATPase p97 allosteric binding site","volume":"15","author":"Burnett","year":"2017","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.bioorg.2026.109868_bb0200","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/s41392-025-02299-4","article-title":"Glioblastoma at the crossroads: current understanding and future therapeutic horizons","volume":"10","author":"Singh","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bioorg.2026.109868_bb0205","doi-asserted-by":"crossref","DOI":"10.1101\/pdb.prot087379","article-title":"Crystal violet assay for determining viability of cultured cells","volume":"2016","author":"Feoktistova","year":"2016","journal-title":"Cold Spring Harb Protoc"},{"key":"10.1016\/j.bioorg.2026.109868_bb0210","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1259\/bjr\/54004230","article-title":"Resazurin assay of radiation response in cultured cells","volume":"78","author":"Anoopkumar-Dukie","year":"2005","journal-title":"Br. J. Radiol."},{"key":"10.1016\/j.bioorg.2026.109868_bb0215","doi-asserted-by":"crossref","first-page":"54952","DOI":"10.18632\/oncotarget.10712","article-title":"Tumor growth accelerated by chemotherapy-induced senescent cells is suppressed by treatment with IL-12 producing cellular vaccines","volume":"7","author":"Simova","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.bioorg.2026.109868_bb0220","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.dnarep.2019.04.001","article-title":"PML nuclear bodies are recruited to persistent DNA damage lesions in an RNF168-53BP1 dependent manner and contribute to DNA repair","volume":"78","author":"Vancurova","year":"2019","journal-title":"DNA Repair (Amst)"},{"key":"10.1016\/j.bioorg.2026.109868_bb0225","doi-asserted-by":"crossref","first-page":"6381","DOI":"10.18632\/aging.204207","article-title":"Synergism of BCL-2 family inhibitors facilitates selective elimination of senescent cells","volume":"14","author":"Rysanek","year":"2022","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.bioorg.2026.109868_bb0230","series-title":"Kinase Antagonists, Univ. California, CA2909277A1","author":"Shokat","year":"2007"},{"key":"10.1016\/j.bioorg.2026.109868_bb0235","first-page":"17","article-title":"Avogadro: an advanced semantic chemical editor, visualization, and analysis platform","volume":"4","author":"Hanwell","year":"2012","journal-title":"J. Chem."},{"key":"10.1016\/j.bioorg.2026.109868_bb0240","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bioorg.2026.109868_bb0245","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","article-title":"AutoDock vina 1.2.0: new docking methods, expanded force field, and python bindings","volume":"61","author":"Eberhardt","year":"2021","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.bioorg.2026.109868_bb0250","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1107\/S2053230X16016356","article-title":"Development of a high-throughput crystal structure-determination platform for JAK1 using a novel metal-chelator soaking system","volume":"72","author":"Caspers","year":"2016","journal-title":"Acta Crystallogr. F Struct. Biol. Commun."},{"key":"10.1016\/j.bioorg.2026.109868_bb0255","series-title":"Crystal Structure of JAK1 in Complex with ADP [5KHW]. Protein Data Bank","author":"Han","year":"2016"},{"key":"10.1016\/j.bioorg.2026.109868_bb0260","doi-asserted-by":"crossref","first-page":"eadl2097","DOI":"10.1126\/sciadv.adl2097","article-title":"Molecular basis of JAK2 activation in erythropoietin receptor and pathogenic JAK2 signaling","volume":"10","author":"Abraham","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.bioorg.2026.109868_bb0265","series-title":"Crystal Structure of JAK2 JH2-K539L [8C08]. Protein Data Bank","author":"Haikarainen","year":"2022"},{"key":"10.1016\/j.bioorg.2026.109868_bb0270","doi-asserted-by":"crossref","first-page":"27261","DOI":"10.1074\/jbc.M115.672048","article-title":"Structural and functional characterization of the JH2 pseudokinase domain of JAK family tyrosine kinase 2 (TYK2)*","volume":"290","author":"Min","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2026.109868_bb0275","series-title":"Crystal Structure of Kinase [5C03]. Protein Data Bank","author":"Min","year":"2015"},{"key":"10.1016\/j.bioorg.2026.109868_bb0280","doi-asserted-by":"crossref","first-page":"eabc1251","DOI":"10.1126\/sciadv.abc1251","article-title":"The 3.2-\u00c5 resolution structure of human mTORC2","volume":"6","author":"Scaiola","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.bioorg.2026.109868_bb0285","series-title":"cryo-EM Structure of Human mTOR Complex 2, Overall Refinement [6ZWM]. Protein Data Bank","author":"Scaiola","year":"2020"},{"key":"10.1016\/j.bioorg.2026.109868_bb0290","doi-asserted-by":"crossref","DOI":"10.1002\/pro.4792","article-title":"UCSF ChimeraX: Tools for structure building and analysis","volume":"32","author":"Meng","year":"2023","journal-title":"Protein Sci."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826004049?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826004049?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:36:37Z","timestamp":1778718997000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826004049"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":58,"alternative-id":["S0045206826004049"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.109868","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The structure-activity relationship study of torkinib derivatives as mTOR inhibitors with senolytic and STAT3 inhibitory activities","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.109868","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109868"}}